01 12Abilify
02 1Abilify
03 15Abilify Maintena
04 1Abilify Maintena/Abilify Asimtufii
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 1,101
2019 Revenue in Millions : 966
Growth (%) : 14
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 369
2019 Revenue in Millions : 319
Growth (%) : 16
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 328
2019 Revenue in Millions : 356
Growth (%) : -8
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 300
2020 Revenue in Millions : 315
Growth (%) : 3
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 369
2020 Revenue in Millions : 363
Growth (%) : 7
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 1,100
2020 Revenue in Millions : 1,056
Growth (%) : 12
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 276
2021 Revenue in Millions : 300
Growth (%) : -8
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 427
2021 Revenue in Millions : 369
Growth (%) : 16
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 1,250
2021 Revenue in Millions : 1,100
Growth (%) : 14
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 1,351
2022 Revenue in Millions : 1,250
Growth (%) : 22
LOOKING FOR A SUPPLIER?